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AbstrACt
Objective To evaluate age-dependent productivity loss 
caused by menstruation-related symptoms, measured 
in absenteeism (time away from work or school) and 
presenteeism (productivity loss while present at work or 
school).
Methods Design/setting: internet-based, cross-sectional 
survey conducted in the Netherlands from July to October 
2017.  Participants: 32 748 women aged 15–45 years, 
recruited through social media.  Outcome measures: self-
reported lost productivity in days, divided into absenteeism 
and presenteeism; impact of menstrual symptoms; 
reasons women give when calling in sick; and women’s 
preferences regarding the implications of menstruation-
related symptoms for schools and workplaces. 
results A total of 13.8% (n=4514) of all women reported 
absenteeism during their menstrual periods with 3.4% 
(n=1108) reporting absenteeism every or almost every 
menstrual cycle. The mean absenteeism related to a 
woman’s period was 1.3 days per year. A total of 80.7% 
(n=26 438) of the respondents reported presenteeism 
and decreased productivity a mean of 23.2 days per 
year. An average productivity loss of 33% resulted in a 
mean of 8.9 days of total lost productivity per year due 
to presenteeism. Women under 21 years were more 
likely to report absenteeism due to menstruation-related 
symptoms (OR 3.3, 95% CI 3.1 to 3.6). When women 
called in sick due to their periods, only 20.1% (n=908) 
told their employer or school that their absence was due 
to menstrual complaints. Notably, 67.7% (n=22 154) of 
the participants wished they had greater flexibility in their 
tasks and working hours at work or school during their 
periods. 
Conclusions Menstruation-related symptoms cause a 
great deal of lost productivity, and presenteeism is a bigger 
contributor to this than absenteeism. There is an urgent 
need for more focus on the impact of these symptoms, 
especially in women aged under 21 years, for discussions 
of treatment options with women of all ages and, ideally, 
more flexibility for women who work or go to school.
bACkgrOund
Menstruation-related symptoms (MRSs) 
are diverse and widespread among women. 
Symptoms include dysmenorrhoea, heavy 
menstrual bleeding and premenstrual mood 
disturbances with reported prevalence of 
45%–90%, 14%–25% and 20%–29%, respec-
tively.1–3 Studies show that women with MRSs 
have lower scores on several domains of quality 
of life such as general health and physical, 
mental, social and occupational functioning 
during their periods.1 4–7 Furthermore, these 
symptoms may create considerable financial 
burdens on patients and their families as well 
as on society.5 6 8–12 Such financial burdens are 
related to the costs of visits to the doctor, over-
the-counter drugs and medical or surgical 
treatment. However, costs related to produc-
tivity loss could be the largest cost driver. 
Productivity costs are defined as costs asso-
ciated with paid and unpaid production loss 
and the replacement of productive people 
due to illness or disability.13 Productivity costs 
can be divided into costs related to absen-
teeism and costs related to presenteeism. 
Absenteeism represents the total amount 
of time off work or away from school, and 
presenteeism represents the loss of produc-
tivity while present at a job or school.
Although the literature is scarce and the 
results are variable, studies on specific patient 
groups generally show that MRSs can cause 
absenteeism.14–16 Research on the association 
between MRSs and presenteeism is even more 
strengths and limitations of this study
 ► This is the largest cohort study to analyse the im-
pact of menstruation-related symptoms on work 
and school productivity.
 ► The survey was performed among the general fe-
male population and is consequently not per se re-
lated to one specific gynaecological condition.
 ► Due to the way of recruitment of participants, there 
may have been some degree of selection bias.
 ► Outcomes are based on self-reported data and 
consequently lack objectivity regarding productivity 
loss.
 ► The generalisability of the study may be limited to 
employment and school systems comparable with 
the Dutch.
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limited. It has been suggested that research into possible 
impairments in quality of life caused by menstrual symp-
toms should not focus on single symptoms but rather on 
a complex of symptoms that vary widely but that are all 
related to the menstrual cycle. This complex includes 
both standard symptoms, like heavy menstrual bleeding 
and abdominal cramps, and also less common symptoms, 
like nausea and cold sweats.17 18
Taking all symptoms into account, it seems likely that 
the real impact of MRSs is underestimated in the general 
population. Despite being almost two decades into the 
21st century, discussions about MRSs may still be rather 
taboo. This survey-based exploratory study aimed to 
quantify the burden of MRSs in the general female popu-
lation, with burden defined as the number of lost days 
at work or school due to absenteeism and presenteeism. 
Furthermore, it was aimed to study the impact of specific 
symptoms on absenteeism and presenteeism.
MethOds
This cross-sectional study consisted of an online survey 
that was distributed from 12 July to 11 October 2017. All 
data were anonymously collected and stored under the 
privacy rules of the Radboud University Medical Center. 
Patients gave informed consent when they initiated the 
questionnaire.
Patient and public involvement
A group of women, among which were several members 
of the Dutch Patient Endometriosis Foundation, women 
with a linguistic education and women with a medical 
origin, was involved in the conduct of this study at several 
stages, that is, in the development and dissemination of 
the questionnaire and in the analysis and interpretation 
of the results. One of the authors of this manuscript, BDB, 
is the chair of the Dutch Patient Endometriosis Founda-
tion. Additional contributions are noted in the Acknowl-
edgements section.
Questionnaire development
The questionnaire had several parts, and online supple-
mentary appendix 1 provides details about the questions. 
Part 1 consisted of questions about each woman’s basic 
characteristics. Part 2 had questions about menstrual 
symptoms, and part 3 had questions related to absen-
teeism and presenteeism. Adaptive questioning was used 
with a maximum of six questions per page. Participants 
were asked in a lay manner how long their menstrual 
cycle was and what the exact meaning of a menstrual cycle 
was. The duration of the cycle was divided in five catego-
ries (25 days or less, 26–30 days, 31–35 days, 36–40 days 
and 41 days or more). Furthermore, participants could 
indicate if they had an irregular cycle, meaning more 
than 10 days difference per cycle, if they were amenor-
rhoeic due to the use of an intrauterine device (IUD) or 
the continuous use of oral contraceptives, or the option 
‘I do not know’. Additional questions about absenteeism 
and presenteeism were included that were based on 
the Productivity Cost Questionnaire from the Institute 
for Medical Technology Assessment (iMTA-PCQ).19 We 
modified the iMTA-PCQ-recommended recall period of 
4 weeks to 3 months so that it was in line with the rele-
vant time period for this study and so we could include 
multiple menstrual periods. We assumed the amount 
of presenteeism to be larger than the amount of absen-
teeism. Therefore, the recall period for absenteeism 
was extended to 6 months to maintain accuracy. Visual 
analogue scales (VAS) were used to quantify the amount 
of pain, or the intensity of the symptom, and the impair-
ment due to pain or the other symptom. Presenteeism 
was measured by asking women to what extent they were 
able to be as productive as possible compared with a day 
without MRSs. This was scored on a scale from 0 to 10, 
with 0 being totally unproductive and 10 fully productive. 
In separate questions, participants were asked to quantify 
their absenteeism that was related to MRSs and absen-
teeism for any other reason than MRSs. For the latter, we 
did not specifically ask the underlying reason.
target population and recruitment
The study population comprised women between 15 and 
45 years old. The upper age limit was chosen to avoid 
interference from menopausal symptoms; the lower 
to have a time margin after the average menarche age, 
since it is known that the first periods are irregular and 
often accompanied with discomfort and uncertainty. 
A large number of women were approached with the 
aim of obtaining a cohort that was representative of the 
general female population in terms of level of education, 
medical history and/or gynaecological diagnosis. Women 
were invited to complete a survey using an online ques-
tionnaire tool20 through a campaign on social media 
platforms Facebook and Twitter. Patient organisations, 
colleagues and visitors of the Facebook page of one of the 
authors (TN) were asked to share the link to the ques-
tionnaire in order to reach the widest possible audience.
On 12 July 2017, a link to the questionnaire was posted 
on Facebook and Twitter through the account of one 
of the authors (TN). In the post, both women with and 
without MRSs were encouraged to fill in the question-
naire. Within 24 hours of the first posting on social media, 
over 6000 respondents had filled in the questionnaire, 
and by July 18, there were 15 000 respondents, which 
was announced by a repost of the link to the question-
naire. A third post was made on Facebook and Twitter on 
16 September 2017, to reach women who may have been 
on holiday when the first posts were created.
data analysis
The outcome measures were presented in a descriptive 
way; we used valid percentages in case of missing values 
where necessary. We distinguished between women who 
were mainly working or mainly studying. Therefore, we 
present these data for two groups, that is, for women who 
worked more than 5 hours per week (‘working group’) 
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and for women who studied more than 5 hours per week 
(‘studying group’).
We used binary logistic regression to calculate ORs. 
Absenteeism and presenteeism were used as dependant 
variables. As independent variables, we used the following 
parameters: women younger than 21 versus women aged 
21 and older, smoking yes or no, reports of absenteeism 
not related to MRSs, educational level, the use of oral 
contraception and the use of an levonorgestrel-releasing 
IUD. All independent variables were used in an univariate 
as well as a multivariate analysis. We also studied the asso-
ciation between pain scores and both absenteeism and 
presenteeism, given that the literature shows that pain 
scores of 0–4, 5–6 and 7 or higher have a different impact 
on activity, mood and sleep.21 22 Analyses were performed 
using IBM SPSS Statistics V.22.00.
Assumptions and transformation of the original data
To present data on level of education in an international 
format, we had to transform the original data, which was 
based on the Dutch school system.23 The categorical data 
of participants’ length of menstrual cycle were trans-
formed into averages.
With regard to the evaluation of absenteeism and 
presenteeism, ‘the guideline for economic evaluations 
in healthcare in the Netherlands’ was used.24 A work day 
accounts for 8 hours. For most sectors in the Netherlands, 
a full-time work-week is 36 hours. The maximum amount 
of working hours per year was set at 1558 when they were 
working full time. We asked women to report their absen-
teeism due to MRSs per cycle and used a recall period of 
6 months.
To calculate the percentages for absenteeism, 1 day of 
absenteeism accounted for 8 hours of lost productivity. 
When a woman reported to study or work more than 
40 hours per week, we transformed these hours to 40 for 
reasons of clarity in the calculations and comparability 
with the data of the Dutch Central Bureau of Statistics 
(CBS). We made a few other transformations for cate-
gorical data. For absenteeism related to MRSs, the cate-
gory ‘more than three days per cycle’ was considered to 
be 4 days per cycle. For absenteeism that was not related 
to MRSs, the category ‘more than ten days in the past 
six months’ was considered to be 11 days in the past 
6 months.
To present yearly data, we multiplied some of these data 
based on the original recall period. The number of days 
for absenteeism related to MRSs was based on days per 
cycle, which were therefore multiplied by 12.7 based on 
the reported average menstrual cycle of 28.8 days (see 
table 1). These values were then multiplied by one if the 
woman reported that she called in sick ‘every period’, 0.75 
if she reported ‘almost every period’, 0.5 if she reported 
‘half of all periods’ and 0.25 if she reported calling in sick 
‘only once in a while’. Values for absenteeism that was not 
related to MRS were based on a recall period of 6 months 
and were therefore multiplied by two in order to obtain 
the number of days per year. The values for presenteeism 
Table 1 Basic characteristics of study participants 
(n=32 748)
Number 
(percentage) Mean±SD Median
Age, years 28.6±8.6 28
  15–19 6141 (18.8)
  20–24 6118 (18.7)
  25–29 5825 (17.8)
  30–34 5483 (16.7)
  35–40 4687 (14.3)
  41–45 4494 (13.7)
Level of education
  Low 4020 (12.3)
  Medium 12 335 (37.9)
  High 16 229 (49.8)
Hours/week
  Paid work 21.7±14.7 24
  Study 7.4±13.6 0
  Voluntary work 0.8±3.1 0
Menstrual cycle
  Regular cycle 25 717 (78.5)
   Duration 28.8±3.0 28
  Amenorrhoea due 
to LG-IUD/OC
3675 (11.2)
  Irregular, 
variation >10 days 
per cycle
2495 (7.6)
  Do not know 861 (2.6)
  Days with blood 
loss per cycle
5.4±1.6 5
Visited a doctor for 
MRSs
  No 17 873 (54.6)
  Yes, general 
practitioner
10 141 (31.0)
  Yes, gynaecologist 4698 (14.4)
Diagnosis for MRSs*
  No 29 731 (90.8)
  Yes 3017 (9.2)
   Endometriosis 1120 (3.4)
   PCOS 588 (1.8)
   Adenomyosis 103 (0.3)
   Fibroids 275 (0.8)
   Other 1901 (5.8)
Contraception*
  Hormonal 
contraception
11 993 (36.6)
   OC 8650 (26.4)
   LG-IUD 2752 (8.4)
Continued
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were based on a recall period of 3 months and were there-
fore multiplied by four.
results
A total of 44 173 women initiated the questionnaire. We 
excluded participants who did not report a date of birth 
or whose age did not fulfil the inclusion criteria (figure 1). 
There were no duplicates of IP addresses. Women who 
did not answer questions related to absenteeism and 
presenteeism were excluded. Furthermore, cases with 
impossible results (eg, 10 000 000 days of presenteeism 
in 3 months or 140 changes of sanitary pads a day) were 
excluded. This resulted in a total of 32 748 women in the 
final analysis.
Table 1 summarises the basic characteristics of the 
participants. We found that 45.4% (n=14 839) had visited 
a doctor for menstrual complaints in the past, with a 
total of 3017 (9.2%) women reporting a diagnosis of a 
menstrual disorder, such as endometriosis or fibroids.
The mean age of women in the working group was 
higher than the mean ager of women in the studying 
group. The mean number of working hours per week 
in the working group was 27.0 (SD 11.4), and the mean 
number of study hours in the studying group was 27.4 
(SD 12.1). A total of 7335 women (22.4%) reported both 
working and studying more than 5 hours per week. In this 
group, 3001 women were working more than 16 hours a 
week, and 5284 women in the study group were studying 
more than 16 hours a week.
Absenteeism
Table 2 shows the results on absenteeism due to MRSs. 
Although 13.8% of the women (n=4514) reported absen-
teeism due to MRSs, only 1108 women (3.4%) reported 
absenteeism every cycle or almost every cycle. The 
percentage of absenteeism in every cycle or almost every 
cycle was 2.4% in the working group and 4.5% in the 
studying group. The mean absenteeism due to MRSs was 
Number 
(percentage) Mean±SD Median
   Other hormonal: 
injection, 
transdermal and 
so on
882 (2.7)
  No hormonal 
contraception
20 755 (63.4)
   Cu-IUD 771 (2.4)
   Female 
sterilisation
423 (1.3)
   No female 
contraception
19 639 (60.0)
Nulliparous 21 585 (66.0)
Paid work >5 hours 
a week
26 104 (79.7)
  Age 29.7±8.3 29
  Hours of paid 
work/week
27.0±11.4 28
  Hours spent on 
study/week
7.5±13.4 0
  >40 hours of paid 
work/week
1047 (3.2)
Study >5 hours a 
week
8764 (26.8)
  Age 22.0±6.2 20
  Hours spent on 
study/week
27.4±12.1 30
  Hours of paid 
work/week
15.5±11.3 12
  >40 hours spent 
on study/week
322 (1.0)
 Mean duration of cycle based on women with a regular cycle.
*More than one answer possible. 
Cu-IUD, copper intrauterine device; LG-IUD, levonorgestrel-
releasing intrauterine device; MRSs, menstruation-related 
symptoms; PCOS, polycystic ovary syndrome; OC, oral 
contraceptive. 
Table 1 Continued 
Figure 1 Flow chart for the respondents.
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0.9 days per year for the working group and 1.6 day per 
year for the study group.
We also calculated the mean total absenteeism that was 
not related to MRSs. For the entire group, this was 3.3 days 
per year; for the working group, it was 3.5 days, and for 
the studying group, it was 4.3 days. The mean percentage 
of absenteeism that was not related to MRSs was 3.5% 
in the working group and 3.7% in the studying group. 
Consequently, absenteeism due to MRSs in our cohort 
accounted for, on average, 22% of the total absenteeism 
in the working group and 24% in the studying group.
Presenteeism
Table 3 shows the numbers reported for presenteeism. 
Over 80 % of all women reported presenteeism during 
their periods. The differences between the working group 
and the study group were not large in terms of prevalence 
and lost productivity. The mean number of lost produc-
tive days per year due to presenteeism was more than 
sevenfold greater than the mean number of lost produc-
tive days due to absenteeism.
Factors associated with absenteeism and presenteeism
Figure 2 shows the association between reported pain 
or discomfort scores and both absenteeism and presen-
teeism. As seen in detail in table 4, high VAS scores were 
significantly associated with higher levels of absenteeism 
and presenteeism. The strongest relationship was found 
for abdominal pain scores that were seven or higher on 
Table 2 Reported absenteeism caused by menstruation-
related symptoms
Number 
(percentage) Mean±SD
All (n=32 748)
Absenteeism 4514 (13.8)
  ≤0.5 day 538 (1.6)
  1 day 2259 (6.9)
  2 days 1171 (3.6)
  3 days 349 (1.1)
  >3 days 184 (0.6)
  Total days of 
absenteeism per year
1.3±5.9
Work (n=26 104)
Absenteeism 2926 (11.2)
  ≤0.5 day 374 (1.4)
  1 day 1476 (5.7)
  2 days 757 (2.9)
  3 days 211 (0.8)
  >3 days 98 (0.4)
  Total days of 
absenteeism per year
0.9±3.9
Study (n=8764)
Absenteeism 1715 (19.6)
  ≤0.5 day 234 (2.7)
  1 day 921 (10.5)
  2 days 423 (4.8)
  3 days 92 (1.0)
  >3 days 41 (0.5)
  Total days of 
absenteeism per year
1.6±5.0
Women were asked to report the average amount of days on which 
they were absent due to menstruation-related symptoms per cycle. 
The total days of absenteeism per year was calculated. The added 
numbers of women in the work and study group exceed the total 
amount of participants, since  2120 women reported to both study 
and work more than 5 hours/week. 
Table 3 Reported presenteeism caused by menstruation-
related symptoms 
Number 
(percentage) Mean±SD Median
All (n=32 748)
Presenteeism 26 438 (80.7)
Number of days in 
the past 3 months
5.8±5.3 5.0
Percentage of 
productivity loss 
per day
33.0±24.8 30.0
Days/year of lost 
productivity
8.9±11.0 5.6
Work (n=26 104)
Presenteeism 21 252 (81.4)
Number of days in 
the past 3 months
5.7±5.2 5.0
Percentage of 
productivity loss 
per day
31.7±24.7 30.0
Days/year of lost 
productivity
8.4±10.6 4.8
Study (n=8764)
Presenteeism 7385 (84.3)
Number of days in 
the past 3 months
6.3±5.3 5.0
Percentage of 
productivity loss 
per day
36.8±24.2 40.0
Days/year of lost 
productivity
10.5±11.8 7.2
Women were asked to report the amount of days on which they 
were less productive and to what extent. The total days of lost 
productivity per year was calculated. The added numbers of 
women in the work and study group exceed the total amount of 
participants, since  2120 women reported to both study and work 
more than 5 hours/week. 
Note that the values presented in days/year of lost productivity 
do not add up exactly, since these data were calculated on an 
individual basis and are not the result of merely multiplying the two 
averages. 
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a scale from 0 to 10. ORs were 5.6 for absenteeism (95% 
CI 5.0 to 6.2) and 8.8 for presenteeism (95% CI 8.1 to 
9.5). Figure 3 shows the association between age and both 
presenteeism and absenteeism. As shown in both figure 3 
and table 4, we found that younger women showed signifi-
cantly higher rates of absenteeism and presenteeism. A 
levonorgestrel-releasing IUD is associated with especially 
less presenteeism.
Menstruation and suggested implications for schools and 
workplaces
From the respondent who had been calling in sick due 
to MRSs, 20.1% (n=908) told their employer or school 
menstrual symptoms were the reason, 46.4% (n=2092) 
only mentioned the presenting symptom. No reason was 
given by 27.7% (n=1250), while 5.8% (n=260) made up 
another reason. Comparing women aged below 21 years 
with women aged 21 years and above, we found that 
younger women were less open about their MRSs being 
the reason for calling in sick (12.0%) versus women 
older than 21 (27.0%). Women were asked to report 
suggestions on how work places and conditions could 
be changed in order for them to function better during 
their menstrual periods. There were 32 708 responses 
to this multiple-choice question, to which each woman 
could give more than one answer. The majority of women 
(67.7%, n=22 154) preferred more flexibility during their 
periods, such as the possibility of doing less physical work 
(32.1%, n=10 499), the ability to work from home (39.5%, 
n=12 917), more time for personal care (28.3%, n=9241) 
or the ability to take a day off and make up for it later 
(11.5%, n=3756). In addition, 32.9% wished they could 
take a complete day off without any consequences. A 
percentage of 27.2 (n=8890) did not wish for any changes 
in policy. Many women (79.7%, n=26 072) were open to 
discussing MRSs with their company doctor, and 56.7% 
(n=18 579) thought that doing so would draw more atten-
tion to MRS-related matters.
disCussiOn
This survey-based study showed that menstruation-re-
lated absenteeism and, to a greater extent, presenteeism 
are widespread in the general female population. In our 
cohort, MRSs accounted for up to 24% of total absen-
teeism for women who were working and studying. The 
annual productivity loss due to presenteeism was seven-
fold times more than the annual productivity loss due to 
absenteeism, and women younger than 21 years experi-
ence the largest burden. Symptom severity scores showed 
significant and strong associations with both absenteeism 
and presenteeism. When women called in sick due to 
MRSs, only one in five stated openly that menstrual symp-
toms were the main reason. A majority of women prefers 
more flexibility during their periods when it comes to 
work or school.
There have been few studies on absenteeism and presen-
teeism related to MRSs in the general female population. 
To our knowledge, Tanaka’s study25 is the only other 
published study on absenteeism and presenteeism due to 
MRSs in the general female population. In a cohort of 
19 254 Japanese women, a total of 3311 (17.2%) reported 
work productivity lost in the prior 3 months, mostly in the 
form of decreased efficiency (62.0%, n=2052). Of these 
2052 subjects, the mean number of workdays lost due to 
decreased efficiency was 5.7 days in 3 months. After recal-
culation, this accounts for 2.4 days per year for the entire 
population. This is fewer days than the 8.9 days per year 
in our cohort. However, the numbers for absenteeism 
were more similar, with a mean of 1.0 day of absenteeism 
per year in the entire Japanese cohort compared with 1.3 
days in our cohort. Differences in regulations of social 
services, a difference in attitude towards sick leave and a 
different method of data collection might explain these 
differences. It has been suggested in research on muscu-
loskeletal symptoms that rates of absenteeism might be 
lower in Japan compared with European countries and 
the USA. Consequently, presenteeism might therefore be 
a more representative variable.26 27
More data are available regarding the impact of dysmen-
orrhoea on quality of life and absenteeism. De Sanctis 
et al reviewed studies on dysmenorrhoea in multiple 
countries, some of which included menstruation-related 
absenteeism data.14 They found that the prevalence of 
school absences in adolescents that was due to dysmenor-
rhoea varied between 7.7% and 57.8%. Since the review 
included 41 140 women in 27 countries, and there was a 
high degree of heterogeneity in the outcome measures, 
no firm conclusions could be drawn. Hailemeskel et al 
evaluated 440 female university students in Ethiopia.28 
Figure 2 The relationship between pain and intensity 
scores, related to absenteeism and presenteeism, in lost 
days per year.
 o
n
 22 July 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026186 on 27 June 2019. Downloaded from 
7Schoep ME, et al. BMJ Open 2019;9:e026186. doi:10.1136/bmjopen-2018-026186
Open access
Table 4 ORs and 95% CIs for factors related to absenteeism and presenteeism
Absenteeism Presenteeism
OR (95% CI)
OR after correction 
(95% CI) OR (95% CI)
OR after correction 
(95% CI)
Age <21 years* 3.7 (3.4 to 3.9) 3.3 (3.1 to 3.6) 1.4 (1.3 to 1.5) 1.3 (1.2 to 1.4)
Smoking† 1.3 (1.2 to 1.5) 1.3 (1.2 to 1.4) 1.5 (1.3 to 1.6) 1.4 (1.3 to 1.6)
Absenteeism not related 
to MRSs in the past 
6 months‡ 
2.2 (2.1 to 2.4) 1.7 (1.6 to 1.9) 1.4 (1.3 to 1.5) 1.3 (1.2 to 1.4)
Level of education§ 
  Low 4.5 (4.1 to 4.9) 2.7 (2.4 to 3.0) 1.3 (1.2 to 1.4) 1.1 (1.0 to 1.2)**
  Medium 2.2 (2.1 to 2.4) 1.7 (1.5 to 1.8) 1.3 (1.2 to 1.4) 1.2 (1.1 to 1.2)
  High 1.0 (n/a) 1.0 (n/a) 1.0 (n/a) 1.0 (n/a)
Oral contraception¶ 
  No 1.0 (n/a) 1.0 (n/a) 1.0 (n/a) 1.0 (n/a)
  Yes 1.2 (1.1 to 1.3) 1.0 (0.9 to 1.1)†† 0.9 (0.9 to 1.0) 0.9 (0.8 to 0.9)
LG-IUD¶ 
  No 1.0 (n/a) 1.0 (n/a) 1.0 (n/a) 1.0 (n/a)
  Yes 0.7 (0.6 to 0.8) 0.9 (0.8 to 1.0) 0.5 (0.5 to 0.6) 0.5 (0.5 to 0.6)
Abdominal pain score¶ 
  0–4 1.0 (n/a) 1.0 (n/a) 1.0 (n/a) 1.0 (n/a)
  5–6 2.6 (2.3 to 2.9) 2.2 (1.9 to 2.4) 5.2 (4.8 to 5.7) 5.3 (4.9 to 5.7)
  >7 7.0 (6.4 to 7.8) 5.6 (5.0 to 6.2) 8.7 (8.0 to 9.4) 8.8 (8.1 to 9.5)
Headache pain score¶ 
  0–4 1.0 (n/a) 1.0 (n/a) 1.0 (n/a) 1.0 (n/a)
  5–6 1.5 (1.3 to 1.6) 1.5 (1.4 to 1.6) 3.0 (2.7 to 3.3) 3.1 (2.8 to 3.4)
  >7 2.0 (1.8 to 2.1) 2.3 (2.1 to 2.5) 3.5 (3.2 to 3.9) 3.7 (3.4 to 4.1)
Backache pain score¶ 
  0–4 1.0 (n/a) 1.0 (n/a) 1.0 (n/a) 1.0 (n/a)
  5–6 1.6 (1.5 to 1.7) 1.4 (1.3 to 1.5) 3.5 (3.2 to 3.9) 3.5 (3.2 to 3.8)
  >7 2.7 (2.5 to 2.9) 2.2 (2.1 to 2.4) 4.7 (4.2 to 5.2) 4.5 (4.0 to 5.0)
Tiredness intensity 
score¶ 
  0–4 1.0 (n/a) 1.0 (n/a) 1.0 (n/a) 1.0 (n/a)
  5–6 1.8 (1.7 to 2.0) 1.8 (1.6 to 2.0) 3.3 (3.1 to 3.6) 3.3 (3.1 to 3.6)
  >7 3.0 (2.8 to 3.2) 2.8 (2.6 to 3.1) 5.1 (4.7 to 5.6) 5.2 (4.7 to 5.7)
Psychological 
complaints intensity 
score¶ 
  0–4 1.0 (n/a) 1.0 (n/a) 1.0 (n/a) 1.0 (n/a)
  5–6 1.6 (1.5 to 1.7) 1.5 (1.4 to 1.7) 2.7 (2.5 to 2.9) 2.6 (2,5 to 2.9)
  >7 2.2 (2.0 to 2.4) 2.1 (2.0 to 2.3) 4.4 (4.0 to 4.7) 4.3 (4.0 to 4.7)
ORs >1 correlate with a higher prevalence of absenteeism or presenteeism. ORs <1 correlate with a lower prevalence of absenteeism or 
presenteeism. 
*Correction for smoking and absenteeism that was not related to menstruation-related symptoms (MRSs). 
†Correction for age, absenteeism that was not related to MRSs and level of education.
‡Correction for age, smoking and level of education.
§Correction for age, smoking and absenteeism that was not related to MRSs.
¶Correction for age, smoking, absenteeism that was not related to MRSs and level of education.
**P=0.26, ††p=0.73 for all other ORs, p<0.05.
LG-IUD, levonorgestrel-releasing intrauterine device.
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Among students with dysmenorrhoea, 66.8% reported a 
loss of concentration in class, and 56.3% reported class 
absences during the last month. In a questionnaire-based 
study of 706 Hispanic female adolescents, 38% reported 
missing school due to dysmenorrhoea during the 3 
months prior to the survey, and 59% reported a decrease 
in concentration in class due to dysmenorrhoea.29
Absenteeism and presenteeism due to endometriosis 
in other studies was greater than in our study, which was 
not surprising.9 14 30 However, some interesting parallels 
can be drawn to findings from a recent study by Soliman 
et al.14 They found that the average number of hours of 
presenteeism, 5.3 hours per week, was far greater than 
the number of hours of absenteeism, which was 1.1 hours 
per week. Furthermore, younger women had significantly 
higher levels of lost productivity than their older coun-
terparts, and more severe symptoms were associated with 
more absenteeism and presenteeism. This was in line with 
our findings, since we also found higher rates of both 
absenteeism and presenteeism in younger women. A 
taboo on talking openly about MRS, undertreatment and 
less flexibility at school might be possible explanations for 
these differences. Comparing our outcomes with studies 
on other non-gynaecological conditions is hard due to 
differences in methods and presentation of findings and 
the cyclic character of MRSs. However, the incidence of 
presenteeism seems to be as high as it is in patients with 
inflammatory bowel disease.31 Moreover, the amount of 
impairment is comparable with severe gastro-oesopha-
geal reflux (31.9%), moderate irritable bowel syndrome 
(36.6%) and allergic rhinitis (33.4%–39.8%)%).32
Our finding that only 20.1% of women were open 
about their menstrual symptoms as a reason for calling 
in sick may confirm the general idea that women tend 
not to speak openly about MRSs. Wong et al found that 
in a cohort of schoolgirls in Malaysia, 76.1% considered 
dysmenorrhoea a normal part of the menstrual cycle.15 
In the context of the findings noted above, our study 
also suggests there is a taboo for women in terms of 
discussing menstrual problems with their employers. The 
latter may therefore conclude that the impact of MRSs 
on their employees is negligible. Considering the fact 
that we also found that 68% of women wish that they had 
greater flexibility during their periods, either at school 
or at work, more openness about MRSs in the employ-
ment setting seems desirable. The reasons underlying 
this taboo are likely to have a historical basis; indeed, 
since ancient times, menstruation has been surrounded 
with mythical stories and has not been well understood. 
However, in recent years, the lay literature in developed 
countries has focused more attention on MRSs.33–35 The 
prevalence and the impact of MRSs on the general popu-
lation and the number of women who are asking for a 
different approach all reflect the need to change the view 
of menstrual symptoms and the way they are addressed 
in society.
This study consisted of a large cohort, and it reached 
a large number of women within the age range that was 
aimed for. The questionnaire was developed in collabora-
tion with patient representatives to make it understand-
able by and relevant to most women. The cohort appeared 
to be a representative sample of the general female popu-
lation based on the number of working hours.33 When 
we compare our data with the national registries, the 
total amount of absenteeism is found to be comparable, 
regardless of whether it was related to MRSs.36 37 It is 
difficult to compare our numbers on women with a diag-
nosis explaining their MRSs with numbers found in other 
studies. We found that only 9% of the participants had 
such a diagnosis, which seems about as expected or even 
somewhat low.3 38–40 In contrast, 45% of the women in the 
study reported consulting a physician for their MRSs. This 
number was relatively high compared with other studies 
in which, for example, the percentage of women with 
dysmenorrhoea who sought medical advice was approxi-
mately 15%.15 16 An important factor might be the Dutch 
health system in which general practitioners are available 
free of charge. Women with a low level of education were 
relatively under-represented.41 As our results show, espe-
cially absenteeism related to MRSs is associated with a low 
level of education, and this might have biased our results. 
We expect women with lower educational levels to do 
more physical jobs or jobs with less flexibility. Therefore, 
our findings on work productivity loss might be under-
estimated. However, our finding could be overestimated 
due to the possibility that women with more MRSs might 
be more likely to respond to a questionnaire, as it may 
seem more relevant to them. Moreover, we were not able 
to provide data on presenteeism not related to MRSs nor 
were we able to correct for comorbid health conditions. 
Thus, these results must be interpreted with caution. Due 
to the way that the questionnaire was distributed through 
Figure 3 The relationship between age and average 
absenteeism and presenteeism.
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social media, there may have been some selection bias. 
However, a recent review stated that Facebook is a useful 
recruitment tool for healthcare research.42 Although we 
did not use a validated questionnaire, our most important 
outcomes were based on questions derived from the PCQ, 
which itself is based on validated questions and which is 
recommended by guidelines for cost research.24 Self-re-
ported absenteeism generally shows a good correlation 
with official records, although accuracy decreases with 
increasing recall period.43 This might have initiated a 
recall bias in our cohort. It is unknown to what extend 
recall bias affects reports on presenteeism.44 In general, 
although results vary among studies on premenstrual 
complaints, a prospective collection of data on symp-
toms is advisable.45 46 Furthermore, an extrapolation 
of a 3-month and 6-month timeframe to a yearly basis 
may intrinsically imply some degree of uncertainty, for 
example, when the influenza season is not included 
in the original analysis. Finally, these results may not 
be generalised internationally due to variability in the 
regulation of social services in different countries, and 
this is also a limitation of our study. In he Netherlands, 
wages are paid during sick leave that has duration of less 
than 1 year, but women in other countries may not have 
this benefit. Since we know that many factors influence 
menstrual symptoms, including biological, cultural, and 
environmental factors, these differences might well influ-
ence both absenteeism and presenteeism.6 14 47
In conclusion, we have found that the impact of MRSs 
on work and school productivity is considerable and that 
presenteeism contributes significantly more to the matter 
than absenteeism. Future research should identify how 
women affected by MRSs could be helped best and how 
their productivity can be improved in order to reduce the 
societal impact regarding absenteeism and presenteeism.
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